MORE posts
Health Analytics
Profiling non-medical use of tapentadol products among recreational drug abusers
Health Analytics
PainCAS now available for Allscripts users: A pain and opioid risk assessment featuring SOAPP® & COMM®
Inflexxion, Inc. announced today that Allscripts has certified PainCAS™ as part of the Allscripts Developer Program. PainCAS enables Allscripts ambulatory EHR users to assess pain, functioning, and risk of problematic opioid-related behaviors in patients with chronic pain. Developed in part with support from the National Institutes of Health (NIH), grants (Grant No. R44DA026359, PI S.F. Butler and Grant No. R44DA015617, PI S.F. Butler), PainCAS is a scientifically validated web-based, patient self-report clinical tool for assessing pain and opioid misuse risk in patients with chronic pain.
Health Analytics
Abuse and route of administration prevalence for tapentadol products within the NAVIPPRO® ASI-MV® surveillance system
Health Analytics
Patterns of abuse of hydrocodone combination products: Results from an Internet survey of recreational drug users
Health Analytics
A Randomized Control Trial Of An Online Self-Management Program for Adults with Arthritis Pain
Health Analytics
The changing abuse ecology: implications for evaluating the abuse pattern of extended-release oxymorphone and abuse-deterrent opioid formulations
Health Analytics
Comparing abuse of extended-release versus immediate-release opioid analgesics adjusted for number of prescriptions and morphine-equivalent dose
Health Analytics
Changes in Prevalence of Prescription Opioid Abuse after Introduction of an Abuse-Deterrent Opioid Formulation
Health Analytics
The Feasibility of Pharmacy-Based Naloxone Distribution Interventions: A Qualitative Study With Injection Drug Users and Pharmacy Staff in Rhode Island
Health Analytics
Abuse of Reformulated OPANA® ER: early findings from NAVIPPRO® data
Health Analytics
Abuse rates and routes of administration of reformulated extended release oxycodone: Initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment
Health Analytics
Change in prescription opioid abuse after introduction of an abuse deterrent formulation